Issue Date: April 25, 2011
Crystallics Forms Via Avantium Buyout
Avantium’s solid-state research and drug preformulation business will become a new company, called Crystallics, following a management buyout. Operating as a contract research organization, Crystallics will specialize in identifying physical forms of compounds and in crystallization process development. Avantium will continue its efforts in high-throughput R&D. It also develops green chemical building blocks.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society